American Society of Hirudotherapy

Lactational Mastitis (Non-Suppurative)

Investigational adjunctive use proposed for non-suppurative lactational mastitis; no clinical study of leech therapy was identified.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for mastitis. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
What evidence exists?
Tier C (investigational). No clinical study of leech therapy for lactational mastitis was identified in the literature searches, so no benefit has been shown. There are no randomized controlled trials. Evidence-based care for non-suppurative lactational mastitis is continued effective milk removal (frequent feeding from the affected side, hand expression, gentle massage), proper latch evaluation by a lactation consultant, anti-inflammatories such as ibuprofen, and oral antibiotics (e.g., dicloxacillin or cephalexin) if symptoms do not improve within 12 to 24 hours or if you are systemically unwell. Imaging is needed if an abscess is suspected.
Main risks
  • Bleeding from each bite site for 6 to 24 hours after the leech detaches
  • Bruising and tenderness around the breast for 5 to 10 days
  • Anemia worsening in a mother already depleted from blood loss after childbirth
  • Aeromonas hydrophila skin infection from leech gut bacteria
  • Triggering progression to a breast abscess if leeches are placed too close to a developing collection
  • Missing or delaying diagnosis of inflammatory breast cancer (which can mimic mastitis)
  • Disruption of breastfeeding routine and milk supply if the mother stops feeding from the affected side
  • Allergic reaction to leech saliva (uncommon)
Who should not consider this
  • Mothers with a confirmed or suspected breast abscess (this needs drainage, not leeches)
  • Mothers with suspected inflammatory breast cancer (requires urgent biopsy and oncology referral)
  • Mothers with postpartum anemia
  • Mothers on anticoagulants, with hemophilia, or with a bleeding disorder
  • Mothers with active systemic infection, sepsis, or fever above 39 C
  • Mothers who have not yet had a thorough latch and milk-removal assessment by a lactation consultant
  • Mothers allergic to ciprofloxacin or other antibiotics needed if Aeromonas develops
What to ask your clinician
  • Have we ruled out a breast abscess with ultrasound, and is inflammatory breast cancer being considered?
  • Have I had a proper lactation consultant evaluation for latch, milk removal, and feeding technique?
  • Has a standard antibiotic course (10 to 14 days of dicloxacillin, cephalexin, or culture-guided alternative) been tried?
  • Where will leeches be placed - confirm they are at the periphery, NEVER on the nipple-areolar complex?
  • What is the plan for continued breastfeeding during and after treatment?
  • What is your Aeromonas-prevention protocol and what antibiotic would I receive if infection develops?
  • How will my hemoglobin be monitored given postpartum recovery?
When to seek urgent care
  • Fever above 39 C / 102.2 F, severe chills, or feeling rapidly unwell (possible severe mastitis or sepsis)
  • A firm, tender, or fluctuant lump in the breast that is enlarging (possible abscess - needs drainage)
  • Spreading redness, red streaks up the chest wall, or skin changes such as orange-peel texture (concerning for inflammatory breast cancer)
  • Bleeding from a bite site soaking through more than one pad per hour or continuing beyond 24 hours
  • Cracked or bleeding nipple with worsening pain after leech sessions
  • Hives, facial swelling, throat tightness, or difficulty breathing
  • Any signs of infection at bite sites (warmth, pus, increasing pain)

What this does NOT mean

  • This is not FDA-cleared for mastitis.
  • No clinical study of leech therapy for lactational mastitis was identified, so it is NOT an alternative to effective milk removal and standard antibiotics.
  • Leech therapy is never appropriate as primary treatment for a breast abscess - that requires drainage.
  • Suspected inflammatory breast cancer must be biopsied promptly and is not a candidate for any complementary therapy.
  • Mechanism plausibility (anti-inflammatory, decongestion) is not a substitute for lactation consultation, which addresses the root cause in most cases.

Clinical Profile

Category
Gynecologic
ICD-10
O91.12, O91.13, N61.0
Safety tier
Medium

Evidence Summary

No clinical study of leech therapy for lactational mastitis was identified in PubMed, Europe PMC, Crossref, ClinicalTrials.gov or Russian- and German-language searches; the rationale is mechanistic only. The proposed rationale is local decongestion and anti-inflammatory effect, typically alongside standard antibiotic therapy — but no clinical outcome data support this. Leeches must NOT be placed on the inflamed area. Critical safety note: suppurative mastitis (abscess) requires drainage and leech therapy must not be used as primary management. Any compatibility with continued breastfeeding, given the associated blood loss, should be confirmed by a lactation consultant. Given the absence of evidence, leech therapy has no established role in mastitis care.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Baskova and Isakhanyan include purulent mastitis in the list of indications for hirudotherapy in gynecology; non-purulent (lactational) mastitis is not mentioned in the book[B1].
  • The only description of treating mastitis they give is a case of purulent mastitis (Tissot-Guerraz et al., 1987): the authors of the book write that in this case hirudotherapy had an antibacterial effect; this is a single case, and the book gives no details of it[B1].
  • In the historical section, speaking of folk medicine in Armenia, the authors mention that leeches were prescribed for mastitis; this is an account of a folk practice, not the results of an observation[B1].
  • Neither Baskova and Isakhanyan nor Michalsen et al. write about breastfeeding during hirudotherapy[B1][B3].
  • Baskova and Isakhanyan recommend refraining from hirudotherapy when body temperature is high[B1].
  • Both books name anemia as a contraindication: Baskova and Isakhanyan — alongside hemophilia and hemorrhagic diatheses; Michalsen et al. (the chapter on contraindications by Flecken and Michalsen) — as a condition in which any treatment involving blood loss is generally contraindicated[B1][B3].
  • Michalsen et al. (the chapter on contraindications by Flecken and Michalsen) write that hirudotherapy during the acute stage of infectious diseases may, in their experience, lead to weakness and impaired wound healing[B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Suppurative mastitis / abscess (requires drainage)
  • Severe maternal anemia
  • Inflammatory breast cancer (must rule out)

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.